{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-065781","form_type":"8-K","ticker":"IOVA","cik":"0001425205","company_name":"IOVANCE BIOTHERAPEUTICS, INC.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.958712+00:00","generated_at":"2026-05-18T09:26:20.804775+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Iovance CFO Bellemin departs effective June 30; SVP Finance Rosinack named interim CFO","bullets":["CFO Jean-Marc Bellemin's resignation accelerated from July 10 to June 30, 2025 by mutual agreement.","Matthew W. Rosinack appointed interim Principal Financial Officer and Principal Accounting Officer effective June 30, 2025.","Rosinack has been SVP, Finance since Sept 2021; prior roles at Berkeley Lights, ZELTIQ Aesthetics, FormFactor, and PwC.","No arrangements, family relationships, or transactions requiring disclosure in connection with Rosinack's appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-065781","json":"https://secwatch.observer/filing/0001104659-25-065781.json","markdown":"https://secwatch.observer/filing/0001104659-25-065781.md","text":"https://secwatch.observer/filing/0001104659-25-065781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925065781/0001104659-25-065781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925065781/tm2519601d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:26:20.804775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}